Methods for treating bullous pemphigoid by administering an il-4r antagonist
US-2026070995-A1 · Mar 12, 2026 · US
Mannent Leda is listed as an inventor on 17 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Mannent Leda |
| Total patents | 17 |
| First publication | Jan 15, 2015 |
| Latest publication | Mar 12, 2026 |
Publications ranked by popularity score, then publication date.
US-2026070995-A1 · Mar 12, 2026 · US
US-2025388685-A1 · Dec 25, 2025 · US
US-2025154267-A2 · May 15, 2025 · US
US-2024360232-A1 · Oct 31, 2024 · US
US-2023146317-A1 · May 11, 2023 · US
US-2022204631-A1 · Jun 30, 2022 · US
US-11214621-B2 · Jan 4, 2022 · US
US-2021363237-A1 · Nov 25, 2021 · US
US-2021363264-A1 · Nov 25, 2021 · US
US-11053309-B2 · Jul 6, 2021 · US
Latest publications not already listed above.
US-2019040147-A1 · Feb 7, 2019 · US
US-2019040146-A1 · Feb 7, 2019 · US
US-2019040126-A1 · Feb 7, 2019 · US
US-10066017-B2 · Sep 4, 2018 · US
US-10059771-B2 · Aug 28, 2018 · US
US-2016185866-A1 · Jun 30, 2016 · US
US-2015017182-A1 · Jan 15, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Regeneron Pharma | 18 |
| Sanofi Biotechnology | 16 |
| Ruddy Marcella | 1 |
| Regeneran Pharmaceuticals Inc | 1 |
| Sanofi Sa | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 17 |
| C07K16/2866 | 17 |
| C07K2317/21 | 15 |
| A61K2039/545 | 14 |
| C07K2317/76 | 13 |